Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study
Abstract Introduction Migraine is a debilitating neurological disease and one of the most common disorders in the world. Although the triptans, potent 5-HT1B/1D receptor agonists, are an effective and widely used acute treatment of migraine, few studies have assessed how their cardiovascular risk wa...
Main Authors: | Hu Li, Maurice Vincent, Xiang Zhang, Ellen B. Dennehy, Robert Goodloe, Sheena K. Aurora, Timothy R. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-04-01
|
Series: | Pain and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40122-020-00167-3 |
Similar Items
-
Solving the conundrum. A migrainous infarction or an infarct-induced migrainous attack?
by: B Hebant, et al.
Published: (2019-01-01) -
Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?
by: Zukiswa Jiki, et al.
Published: (2018-05-01) -
A systematic review on association between smokeless tobacco & cardiovascular diseases
by: Ruchika Gupta, et al.
Published: (2018-01-01) -
Exploring Unconventional Risk-Factors for Cardiovascular Diseases: Has Opioid Therapy Been Overlooked?
by: Oluwabunmi Ogungbe, et al.
Published: (2019-07-01) -
Stroke and cardiovascular risk factors among working-aged Finnish migraineurs
by: Marja-Liisa Sumelahti, et al.
Published: (2021-06-01)